Ivermectin is primarily used in humans to treat a wide range of parasite illnesses, making it an important medicine in both public health and therapeutic settings. One of its most important uses is in the treatment of Onchocerciasis, often known as river blindness, which is caused by the parasite Onchocerca volvulus. Iverheal 12mg Tablet is also effective against lymphatic filariasis caused by Wuchereria bancrofti, as well as strongyloidiasis produced by Strongyloides stercoralis. The recommended dosage for these situations is 150 to 200 micrograms per kilogram of body weight, given as a single oral dose.
In addition to these permitted applications, ivermectin is increasingly being used off-label to treat scabies, head lice, and other parasitic skin diseases, indicating its broad-spectrum effectiveness against a variety of parasites. Beyond its proven usage, Ivecop 12 Tablet has received interest for its potential efficacy in treating other disorders, such as some viral infections and inflammatory diseases, however these applications are still being investigated. The drug's safety profile is usually positive, with few adverse effects observed, which often include minor responses like headaches or stomach discomfort. However, healthcare practitioners must monitor patients, especially in situations of severe infections or populations with weakened immune systems, where greater parasite burdens may demand further dosages or combination therapy.